
Israeli Can-Fite BioPharma Announces Approval of ADR Listing on NYSE MKT
– The cancer and inflammatory drug development company will list its Level II ADRs on the NYSE MKT on Tuesday , November 19, 2013 under the ticker symbol “CANF”. – Israeli Can-Fite BioPharma More...